147 related articles for article (PubMed ID: 7819053)
1. Lymphomas with testicular localisation show a consistent BCL-2 expression without a translocation (14;18): a molecular and immunohistochemical study.
Lambrechts AC; Looijenga LH; van't Veer MB; van Echten J; Timens W; Oosterhuis JW
Br J Cancer; 1995 Jan; 71(1):73-7. PubMed ID: 7819053
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
[TBL] [Abstract][Full Text] [Related]
3. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
Ngan BY; Chen-Levy Z; Weiss LM; Warnke RA; Cleary ML
N Engl J Med; 1988 Jun; 318(25):1638-44. PubMed ID: 3287162
[TBL] [Abstract][Full Text] [Related]
4. Major and minor breakpoint sites of chromosomal translocation t(14;18) in subtypes of non-Hodgkin's lymphomas.
Klefstrom J; Franssila K; Peltomäki P; Kaartinen M; Solin ML; Knuutila S
Leuk Res; 1994 Apr; 18(4):245-50. PubMed ID: 8170168
[TBL] [Abstract][Full Text] [Related]
5. The bcl-2 gene and protein in malignant lymphomas.
Cleary ML
Bull Cancer; 1991; 78(2):187-93. PubMed ID: 1903662
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
Weiss LM; Warnke RA; Sklar J; Cleary ML
N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
[TBL] [Abstract][Full Text] [Related]
7. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
[TBL] [Abstract][Full Text] [Related]
8. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus.
Bhagat SK; Medeiros LJ; Weiss LM; Wang J; Raffeld M; Stetler-Stevenson M
Am J Clin Pathol; 1993 May; 99(5):604-8. PubMed ID: 8388163
[TBL] [Abstract][Full Text] [Related]
9. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma.
LeBrun DP; Ngan BY; Weiss LM; Huie P; Warnke RA; Cleary ML
Blood; 1994 Jan; 83(1):223-30. PubMed ID: 8274737
[TBL] [Abstract][Full Text] [Related]
10. [Cytogenetic and molecular aspects in MALT lymphomas].
Robledo M; Santos M; Santón A; Echezarreta G; Rivas C; Benítez J
Sangre (Barc); 1991 Aug; 36(4):295-9. PubMed ID: 1776108
[TBL] [Abstract][Full Text] [Related]
11. [BCL-2 in primary central nervous system lymphomas. Immunohistochemistry and molecular biology].
Buccoliero AM; Castiglione F; Caldarella A; Rossi Degl'Innocenti D; Taddei A; Ammannati F; Mennonna P; Taddei GL
Pathologica; 2004 Oct; 96(5):425-9. PubMed ID: 15688978
[TBL] [Abstract][Full Text] [Related]
12. Expression of the bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease.
Lorenzen J; Hansmann ML; Pezzella F; Hesse C; Kneba M; Gatter KC; Fischer R
Hum Pathol; 1992 Nov; 23(11):1205-9. PubMed ID: 1427749
[TBL] [Abstract][Full Text] [Related]
13. bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements.
Papakonstantinou G; Verbeke C; Hastka J; Bohrer M; Hehlmann R
Br J Haematol; 2001 May; 113(2):383-90. PubMed ID: 11380403
[TBL] [Abstract][Full Text] [Related]
14. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
[TBL] [Abstract][Full Text] [Related]
15. The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease.
Gupta RK; Lister TA; Bodmer JG
Leukemia; 1994 Aug; 8(8):1337-41. PubMed ID: 8057670
[TBL] [Abstract][Full Text] [Related]
16. Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: implications for mechanisms of tumor progression.
Reed JC; Tanaka S
Leuk Lymphoma; 1993 Jun; 10(3):157-63. PubMed ID: 8220113
[TBL] [Abstract][Full Text] [Related]
17. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
Lee JT; Innes DJ; Williams ME
J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes.
Corbally N; Grogan L; Keane MM; Devaney DM; Dervan PA; Carney DN
Am J Clin Pathol; 1994 Jun; 101(6):756-60. PubMed ID: 8209865
[TBL] [Abstract][Full Text] [Related]
19. [t(14:18) chromosomal translocation and over expression of bcl-2 protein in follicular type non-Hodgkin's lymphoma].
Wang J; Li G; Liu Z
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):337-40. PubMed ID: 8732086
[TBL] [Abstract][Full Text] [Related]
20. New type of t(14;18) in a non-Hodgkin's lymphoma provides insight in molecular events in early B-cell differentiation.
Meijerink JP; Raemaekers JM; Mensink EJ
Br J Haematol; 1995 Nov; 91(3):630-9. PubMed ID: 8555066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]